Corporate Genetics

by jeeg 21. August 2013 22:10
In June the U.S. Supreme Court ruled that patents on genes were invalid. Yet corporate intellectual-property claims can still harm patients. The court struck down patents held by Myriad Genetics on two human genes linked to breast and ovarian cancers, BRCA1 and BRCA2. The decision ended the c... [More]

Intellectual Property Rights Gone Wild

by jeeg 14. May 2013 23:54
The Supreme Court recently began deliberations in a case that highlights a deeply problematic issue concerning intellectual property rights: Can human genes—your genes—be patented? Put another way, should someone essentially be permitted to own the right, say, to test whether you hav... [More]

IP Rules for Synthetic Bio Generate More Questions Than Answers

by jeeg 13. May 2011 23:05
The biotechnology world was rocked a year ago this month, when J. Craig Venter, Ph.D., reported that he led a team of 17 researchers at his namesake institute in completing the second of three key steps toward creating a fully synthetic organism. The team created the largest man-made DNA struc... [More]
Log in